ERIN CHRISTMAS: Open Payments
NPI 1003493487 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 15 payments from 8 companies in 2025. Trend: 2023 $69 · 2024 $260 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Sage Therapeutics, LLC | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Lundbeck LLC | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Azstarys, COBENFY, ZURZUVAE, CAPLYTA, AUSTEDO XR, REXULTI, SPRAVATO, UZEDY.
Industry payments across WI — which companies pay providers there.
